Efficacy and Safety of AIN457 (Secukinumab) in Patients With Relapsing Multiple Sclerosis
Clinical trial NCT01874340 · TERMINATED
Trial details
- NCT number
- NCT01874340
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-06-01
- Primary completion
- 2014-04-01
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.